title: Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer.
authors.affiliation: Department of Medicine, Weill Cornell Medical College, New York, NY.
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Jakubowski
authors.affiliation: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Plodkowski
authors.affiliation: Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Jason C
authors.initials: JC
authors.lastname: Chang
authors.affiliation: Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Natasha
authors.initials: N
authors.lastname: Rekhtman
authors.affiliation: Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Afsheen
authors.initials: A
authors.lastname: Iqbal
authors.affiliation: Department of Medicine, Weill Cornell Medical College, New York, NY; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Paul K
authors.initials: PK
authors.lastname: Paik
authors.affiliation: Department of Medicine, Weill Cornell Medical College, New York, NY; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: yuh@mskcc.org.
authors.forename: Helena A
authors.initials: HA
authors.lastname: Yu
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000188:drug therapy; D000077716:Afatinib; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis*; D000069347:Erlotinib Hydrochloride / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D018773:Genes, erbB-1 / Q000235:genetics; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000209:etiology; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D009362:Neoplasm Metastasis; D011799:Quinazolines / Q000627:therapeutic use*; D012074:Remission Induction; D014057:Tomography, X-Ray Computed; D028761:Withholding Treatment
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077716:Afatinib; D000069347:Erlotinib Hydrochloride
keywords: Drug toxicity; Drug-induced pneumonitis; EGFR-mutant lung cancer; EGFR-tyrosine kinase inhibitors; Interstitial lung disease